Yordan Ivanov Yordanov

Dr. Yordan Ivanov Yordanov

Pharmacology, Pharmacotherapy and Toxicology, FACULTY OF PHARMACY MEDICAL UNIVERSITY, Sofia, Sofia-Grad, Bulgaria
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
DADenitsa Aluani
Denitsa Aluani
VTVirginia Tzankova
Virginia Tzankova
MKMagdalena Kondeva-Burdina
Magdalena Kondeva-Burdina
YYYordan Ivanov Yordanov
Yordan Ivanov Yordanov
ENElena Nikolova
Elena Nikolova
KYKrassimira Yoncheva
Krassimira Yoncheva

1 August 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
VTVirginia Tzankova
Virginia Tzankova
DADenitsa Aluani
Denitsa Aluani
MKMagdalena Kondeva-Burdina
Magdalena Kondeva-Burdina
YYYordan Ivanov Yordanov
Yordan Ivanov Yordanov
FOFeodor Odzhakov
Feodor Odzhakov
KYKrassimira Yoncheva
Krassimira Yoncheva

1 June 2019 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
BTBorislav Tzankov
Borislav Tzankov
VTVirginia Tzankova
Virginia Tzankova
DADenitsa Aluani
Denitsa Aluani
YYYordan Ivanov Yordanov
Yordan Ivanov Yordanov
Ivanka SpassovaIvanka Spassova
Ivanka Spassova
KYKrassimira Yoncheva
Krassimira Yoncheva

18 May 2024 in Gels
Verified
Journal Article
Open access
PDF file
Lyubomira RadevaLyubomira Radeva
Lyubomira Radeva
YYYordan Ivanov Yordanov
Yordan Ivanov Yordanov
Ivanka SpassovaIvanka Spassova
Ivanka Spassova
Daniela KovachevaDaniela Kovacheva
Daniela Kovacheva
ITIvanka Petkova Pencheva - El Tibi
Ivanka Petkova Pencheva - El Tibi
Krassimira YonchevaKrassimira Yoncheva
Krassimira Yoncheva
Resveratrol could be applied in wound healing therapies because of its antioxidant, anti-inflammatory and antibacterial effects. However, the main limitation of resveratrol is its low aqueous solubility. In this study, resveratrol was included in hydroxypropyl-β-cyclodextrin complexes and further formulated in Pluronic F-127 hydrogels for wound treatment therapy. IR-spectroscopy and XRD analysis confirmed the successful incorporation of resveratrol into complexes. The wound-healing ability of these complexes was estimated by a scratch assay on fibroblasts, which showed a tendency for improvement of the effect of resveratrol after complexation. The antimicrobial activity of resveratrol in aqueous dispersion and in the complexes was evaluated on methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, and Candida albicans strains. The results revealed a twofold decrease in the MIC and stronger inhibition of the metabolic activity of MRSA after treatment with resveratrol in the complexes compared to the suspended drug. Furthermore, the complexes were included in Pluronic hydrogel, which provided efficient drug release and appropriate viscoelastic properties. The formulated hydrogel showed excellent biocompatibility which was confirmed via skin irritation test on rabbits. In conclusion, Pluronic hydrogel containing resveratrol included in hydroxypropyl-β-cyclodextrin complexes is a promising topical formulation for further studies directed at wound therapy.

10 July 2017 in Biotechnology & Biotechnological Equipment
Verified
Journal Article
Open access
DADenitsa Aluani
Denitsa Aluani
VTVirginia Tzankova
Virginia Tzankova
YYYordan Ivanov Yordanov
Yordan Ivanov Yordanov
MKMagdalena Kondeva-Burdina
Magdalena Kondeva-Burdina
KYKrassimira Yoncheva
Krassimira Yoncheva
The aim of the present study was to evaluate the protective effects of free and encapsulated quercetin against oxidative stress injury in neuronal SH-SY5Y cells and isolated rat brain synaptosomes. Quercetin (QR) was encapsulated in nanoparticles consisting of sodium alginate and chitosan and the ratio between both biopolymers was 10:1 or 1:10, respectively. The nanoparticles formulated with higher amount of sodium alginate were negatively charged, whereas those with higher chitosan amount were positively charged. The protective effects of free and encapsulated quercetin were studied in two in vitro models: H2O2-induced oxidative stress in human neuroblastoma SH-SY5Y cells and 6-hydroxydopamine (6-OHDA) induced neurotoxicity in isolated rat brain synaptosomes. Comparing to free quercetin, quercetin encapsulated in the nanoparticles formulated with higher chitosan concentration exerted more pronounced neuroprotective activity in a model of H2O2-induced (1 mmol/L H2O2, 15 min) oxidative stress in neuroblastoma SH-SY5Y cells. A similar trend was observed in a model of 6-OHDA induced neurotoxicity in rat brain synaptosomes. In conclusion, encapsulation of quercetin in nanoparticles based predominantly on chitosan improved its neuroprotective activity in vitro.

1 March 2019 in Drug and Chemical Toxicology
Verified
Journal Article
Closed access
VTVirginia Tzankova
Virginia Tzankova
DADenitsa Aluani
Denitsa Aluani
YYYordan Ivanov Yordanov
Yordan Ivanov Yordanov
MVMassimo Valoti
Massimo Valoti
Maria FrosiniMaria Frosini
Maria Frosini
BTBorislav Tzankov
Borislav Tzankov
Lomefloxacin (LF) is interesting as a model molecule from a safety point of view because of its high potential for serious adverse drug effects (i.e. phototoxic reactions). In this study, MCM-41 mesoporous silica nanoparticles (MCM-41) were loaded with lomefloxacin, aiming to overcome the drug’s intrinsic cytotoxicity. The good biocompatibility of the empty drug carrier (0.1–1.0 mg/ml) was established by the absence of red blood cell lysis (hemolysis assay). The cytotoxicity of empty MCM-41 and lomefloxacin-loaded MCM-41 (LF-MCM-41) was evaluated by using a battery of in vitro cytotoxicity assays: Alamar blue, lactate dehydrogenase release and reactive oxygen species formation by dichlorofluorescein assay. Three cell cultures models: hepatoma HepG2, fibroblasts L929 and endothelial EA.hy926 cells were used to compare the cytotoxicity and reactive oxygen species formation by free drug, empty MCM-41, and LF-MCM-41. The findings from the study indicated that empty MCM-41 (0.1–1.0 mg/ml) showed a low cytotoxic potential in HepG2, followed by L929 and EA.hy926 cells. Lomefloxacin loading in MCM-41 mesoporous silica nanocarrier reduced the cytotoxicity of the free lomefloxacin, especially in the high concentration (1.0 mg/ml MCM-41, containing 120 µg/ml LF). L929 and EA.hy926 cells were more sensitive to the protective effects of LF-MCM-41, compared to HepG2 cells. The results indicate that an improvement in lomefloxacin safety might be expected after incorporation in an appropriate drug delivery system.